查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1947848

體外診斷（IVD）契約製造市場分析及至2035年預測：按類型、產品、服務、技術、組件、應用、最終用戶、流程和設備分類

IVD Contract Manufacturing Market Analysis and Forecast to 2035: Type, Product, Services, Technology, Component, Application, End User, Process, Device
出版日期: | 出版商: Global Insight Services | 英文 313 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

體外診斷（IVD）契約製造市場預計將從2024年的188億美元成長到2034年的549億美元，複合年成長率約為11%。 IVD契約製造市場涵蓋了為原始設備製造商（OEM）生產體外診斷醫療設備的專業公司所提供的服務。這些製造商在產品開發、法規遵循和可擴展生產方面擁有豐富的專業知識。隨著對個人化醫療和就地檢驗需求的成長，該市場持續擴張。診斷領域對成本效益、品質保證和技術進步的關注正在推動市場成長，使其成為醫療保健供應鏈的關鍵組成部分。

體外診斷（IVD）契約製造市場正經歷強勁成長，這主要得益於市場對經濟高效且擴充性的診斷解決方案日益成長的需求。試劑和耗材細分市場是成長最快的子細分市場，這主要歸功於其在診斷分析和測試中的關鍵作用。生物技術的進步和慢性病盛行率的上升進一步推動了該細分市場的成長。儀器細分市場緊隨其後，專注於能夠提高實驗室效率和準確性的自動化和高通量系統。分子診斷已成為領先的子細分市場，這反映了其在個人化醫療和傳染病檢查中的重要性。免疫檢測細分市場也展現出良好的成長前景，這得益於其在各個診斷領域的廣泛應用。將生產流程外包給專業契約製造製造商的趨勢正在加速發展，這帶來了柔軟性和成本節約。這些趨勢凸顯了市場的動態特性，並為體外診斷契約製造領域的相關人員帶來了盈利的機會。

市場區隔
類型 試劑、試劑盒、設備、耗材、軟體
產品 臨床化學、分子診斷、免疫檢測、血液學、微生物學、凝血
服務 契約製造、檢測方法開發、分析服務、法規支援、物流
科技 聚合酶鍊式反應（PCR）、次世代定序（NGS）、酵素連結免疫吸附試驗（ELISA）、質譜分析、流式細胞技術
成分 抗體、核酸、酵素、緩衝液、穩定劑
目的 感染疾病、癌症、心臟病學、糖尿病、腎臟病學
最終用戶 醫院、診斷檢查室、研究機構、生物製藥公司
過程 配製、冷凍乾燥、填充、包裝、貼標
裝置 桌上型、可攜式、手持式、全自動、半自動

在體外診斷契約製造市場，現有企業憑藉創新的定價策略和突破性的產品推出，佔據了大部分市場佔有率。該市場的特點是競爭性定價和策略性產品推出之間動態的相互作用，不斷重塑市場動態。隨著各公司努力實現差異化，對品質和創新的關注仍然至關重要。對客製化解決方案和最尖端科技整合的需求進一步加劇了這種競爭態勢，而這些對於維持市場主導地位至關重要。競爭標竿研究揭示了主要產業參與者之間的激烈競爭。策略聯盟和併購正在重塑競爭格局，而監管的影響，尤其是在北美和歐洲，對於決定市場走向至關重要，因為它決定了合規性和品質標準。儘管這些監管帶來了挑戰，但它們也提供了一個結構化的框架，促進了創新並確保了市場穩定。我們的市場分析強調了了解法規環境的重要性，以便應對複雜的局面並有效地掌握新的機會。

主要趨勢和促進因素：

體外診斷（IVD）契約製造市場正經歷強勁成長，這主要得益於幾個關鍵的市場趨勢和促進因素。慢性病和感染疾病的日益增加是關鍵促進因素，這催生了對先進診斷解決方案的需求。這種需求推動了對高效且擴充性的生產流程的迫切需要，使得契約製造成為許多公司的策略選擇。另一個趨勢是診斷設備的快速技術進步，這需要專業的製造能力。這些進步正在推動創新，並為契約製造製造商提供尖端解決方案創造了機會。此外，對個人化醫療的日益重視也在影響著市場，要求製造商生產滿足特定患者需求的客製化診斷試劑盒。法規遵循和品質保證也是關鍵促進因素。隨著監管標準的日益嚴格，企業正在轉向擁有成熟合規經驗的契約製造製造商。此外，對成本效益和更快上市時間的需求也是外包生產流程的強大驅動力。這些趨勢共同為體外診斷契約製造市場的成長創造了沃土。

目錄

第1章執行摘要

第2章 市場亮點

第3章 市場動態

  • 宏觀經濟分析
  • 市場趨勢
  • 市場促進因素
  • 市場機遇
  • 市場限制
  • 複合年均成長率：成長分析
  • 影響分析
  • 新興市場
  • 技術藍圖
  • 戰略框架

第4章 細分市場分析

  • 市場規模及預測：依類型
    • 試劑
    • 成套工具
    • 裝置
    • 消耗品
    • 軟體
  • 市場規模及預測：依產品分類
    • 臨床化學
    • 分子診斷
    • 免疫檢測
    • 血液學
    • 微生物學
    • 凝血
  • 市場規模及預測：依服務分類
    • 契約製造
    • 檢測方法開發
    • 分析服務
    • 監理合規支持
    • 後勤
  • 市場規模及預測：依技術分類
    • PCR
    • 次世代定序（NGS）
    • ELISA
    • 質譜分析
    • 流式細胞技術
  • 市場規模及預測：依組件分類
    • 抗體
    • 核酸
    • 酵素
    • 緩衝溶液
    • 穩定器
  • 市場規模及預測：依應用領域分類
    • 感染疾病
    • 癌症
    • 心臟病學
    • 糖尿病
    • 腎臟病學
  • 市場規模及預測：依最終用戶分類
    • 醫院
    • 診斷檢查室
    • 研究所
    • 生物製藥公司
  • 市場規模及預測：依製程分類
    • 配方
    • 冷凍乾燥
    • 填充
    • 包裝
    • 標籤
  • 市場規模及預測：依設備分類
    • 桌面型
    • 可攜式的
    • 手持式
    • 自動的
    • 半自動

第5章 區域分析

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 其他拉丁美洲地區
  • 亞太地區
    • 中國
    • 印度
    • 韓國
    • 日本
    • 澳洲
    • 台灣
    • 亞太其他地區
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 西班牙
    • 義大利
    • 其他歐洲地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非
    • 撒哈拉以南非洲
    • 其他中東和非洲地區

第6章 市場策略

  • 需求與供給差距分析
  • 貿易和物流限制
  • 價格、成本和利潤率趨勢
  • 市場滲透率
  • 消費者分析
  • 法規概述

第7章 競爭訊息

  • 市場定位
  • 市場占有率
  • 競爭基準
  • 主要企業的策略

第8章：公司簡介

  • Alere
  • Bio-Techne
  • Bio-Rad Laboratories
  • Dia Sorin
  • ELITech Group
  • Fujirebio
  • Grifols
  • Hologic
  • Kreatech Diagnostics
  • Luminex Corporation
  • Meridian Bioscience
  • Ortho Clinical Diagnostics
  • Perkin Elmer
  • Quidel Corporation
  • Randox Laboratories
  • Roche Diagnostics
  • Sekisui Diagnostics
  • Sysmex Corporation
  • Thermo Fisher Scientific
  • Werfen

第9章：關於我們

簡介目錄
Product Code: GIS24908

IVD Contract Manufacturing Market is anticipated to expand from $18.8 billion in 2024 to $54.9 billion by 2034, growing at a CAGR of approximately 11%. The IVD Contract Manufacturing Market encompasses services provided by specialized firms to produce in vitro diagnostic devices for OEMs. These manufacturers offer expertise in product development, regulatory compliance, and scalable production. As demand for personalized medicine and point-of-care testing rises, the market is expanding. Emphasis on cost-efficiency, quality assurance, and technological advancements in diagnostics propels growth, making it a crucial component in the healthcare supply chain.

The IVD Contract Manufacturing Market is experiencing robust growth, propelled by the increasing demand for cost-effective and scalable diagnostic solutions. The reagents and consumables segment is the top-performing sub-segment, driven by their essential role in diagnostic assays and tests. This segment's growth is further bolstered by advancements in biotechnology and the rising prevalence of chronic diseases. The instruments segment follows closely, with a focus on automated and high-throughput systems that enhance laboratory efficiency and accuracy. Molecular diagnostics emerges as a significant sub-segment, reflecting its critical importance in personalized medicine and infectious disease testing. The immunoassay segment also shows promising growth, supported by its widespread application in various diagnostic fields. The trend towards outsourcing manufacturing processes to specialized contract manufacturers is gaining momentum, offering flexibility and cost savings. These developments underscore the market's dynamic nature and highlight lucrative opportunities for stakeholders in the IVD contract manufacturing landscape.

Market Segmentation
TypeReagents, Kits, Instruments, Consumables, Software
ProductClinical Chemistry, Molecular Diagnostics, Immunoassays, Hematology, Microbiology, Coagulation
ServicesCustom Manufacturing, Assay Development, Analytical Services, Regulatory Support, Logistics
TechnologyPCR, NGS, ELISA, Mass Spectrometry, Flow Cytometry
ComponentAntibodies, Nucleic Acids, Enzymes, Buffers, Stabilizers
ApplicationInfectious Diseases, Cancer, Cardiology, Diabetes, Nephrology
End UserHospitals, Diagnostic Laboratories, Research Institutes, Biopharmaceutical Companies
ProcessFormulation, Lyophilization, Filling, Packaging, Labeling
DeviceBenchtop, Portable, Handheld, Automated, Semi-automated

In the IVD Contract Manufacturing Market, market share is predominantly held by established players, driven by innovative pricing strategies and the introduction of groundbreaking products. The landscape is characterized by a dynamic interplay of competitive pricing and strategic product launches, which continuously reshape market dynamics. As companies strive to differentiate themselves, the focus on quality and technological advancements remains paramount. This competitive spirit is further fueled by the demand for customized solutions and the integration of cutting-edge technologies, which are pivotal in maintaining market leadership. Competition benchmarking reveals a robust rivalry among key industry participants, with strategic partnerships and mergers shaping the competitive landscape. Regulatory influences, particularly in North America and Europe, are pivotal in defining market trajectories, as they dictate compliance and quality standards. These regulations, while challenging, also provide a structured framework that propels innovation and ensures market stability. The market analysis highlights the importance of understanding these regulatory environments to navigate the complexities and capitalize on emerging opportunities effectively.

Geographical Overview:

The IVD contract manufacturing market is witnessing robust growth across various regions, each presenting unique opportunities. North America leads the charge, driven by technological advancements and increased demand for efficient diagnostic solutions. The presence of established healthcare infrastructure and major industry players further bolsters the region's market dominance. Europe follows closely, characterized by a strong focus on innovation and regulatory compliance. The region's emphasis on quality and precision in diagnostics fosters a thriving ecosystem for IVD contract manufacturing. In Asia Pacific, rapid economic development and rising healthcare expenditures are propelling market expansion. Countries such as China and India are emerging as key players, with significant investments in healthcare infrastructure and biotechnology. Latin America and the Middle East & Africa are also showing promising growth. In Latin America, increased awareness of advanced diagnostic solutions is driving demand, while in the Middle East & Africa, government initiatives and investments in healthcare are creating new growth pockets for the IVD contract manufacturing market.

Global tariffs and geopolitical tensions are critically influencing the IVD Contract Manufacturing Market, particularly in East Asia. In Japan and South Korea, firms are navigating tariff-induced cost pressures by enhancing local production capabilities and fostering innovation in diagnostic technologies. China, amid export constraints, is accelerating its focus on self-sufficiency and indigenous manufacturing of IVD components. Taiwan, while pivotal in the supply chain, remains vulnerable to geopolitical frictions, necessitating strategic partnerships and diversification. The parent market for IVDs is robust, driven by advancements in healthcare and diagnostics. By 2035, the market is projected to experience significant growth, underpinned by technological innovation and regional collaboration. Middle East conflicts could exacerbate supply chain disruptions and elevate energy prices, influencing operational costs and market dynamics globally.

Key Trends and Drivers:

The IVD Contract Manufacturing Market is experiencing robust growth, propelled by several key trends and drivers. The increasing prevalence of chronic and infectious diseases is a significant driver, necessitating advanced diagnostic solutions. This demand fuels the need for efficient and scalable manufacturing processes, positioning contract manufacturing as a strategic choice for many companies. Another trend is the rapid technological advancements in diagnostic devices, which require specialized manufacturing capabilities. These advancements are driving innovation and creating opportunities for contract manufacturers to offer cutting-edge solutions. Furthermore, the growing emphasis on personalized medicine is influencing the market, as manufacturers need to produce customized diagnostic kits that cater to specific patient needs. Regulatory compliance and quality assurance are also critical drivers. As regulatory standards become more stringent, companies are turning to contract manufacturers with proven expertise in compliance. Additionally, cost-efficiency and the need to reduce time-to-market are compelling factors for outsourcing manufacturing processes. These dynamics create a fertile landscape for growth in the IVD Contract Manufacturing Market.

Research Scope:

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

  • 1.1 Market Size and Forecast
  • 1.2 Market Overview
  • 1.3 Market Snapshot
  • 1.4 Regional Snapshot
  • 1.5 Strategic Recommendations
  • 1.6 Analyst Notes

2 Market Highlights

  • 2.1 Key Market Highlights by Type
  • 2.2 Key Market Highlights by Product
  • 2.3 Key Market Highlights by Services
  • 2.4 Key Market Highlights by Technology
  • 2.5 Key Market Highlights by Component
  • 2.6 Key Market Highlights by Application
  • 2.7 Key Market Highlights by End User
  • 2.8 Key Market Highlights by Process
  • 2.9 Key Market Highlights by Device

3 Market Dynamics

  • 3.1 Macroeconomic Analysis
  • 3.2 Market Trends
  • 3.3 Market Drivers
  • 3.4 Market Opportunities
  • 3.5 Market Restraints
  • 3.6 CAGR Growth Analysis
  • 3.7 Impact Analysis
  • 3.8 Emerging Markets
  • 3.9 Technology Roadmap
  • 3.10 Strategic Frameworks
    • 3.10.1 PORTER's 5 Forces Model
    • 3.10.2 ANSOFF Matrix
    • 3.10.3 4P's Model
    • 3.10.4 PESTEL Analysis

4 Segment Analysis

  • 4.1 Market Size & Forecast by Type (2020-2035)
    • 4.1.1 Reagents
    • 4.1.2 Kits
    • 4.1.3 Instruments
    • 4.1.4 Consumables
    • 4.1.5 Software
  • 4.2 Market Size & Forecast by Product (2020-2035)
    • 4.2.1 Clinical Chemistry
    • 4.2.2 Molecular Diagnostics
    • 4.2.3 Immunoassays
    • 4.2.4 Hematology
    • 4.2.5 Microbiology
    • 4.2.6 Coagulation
  • 4.3 Market Size & Forecast by Services (2020-2035)
    • 4.3.1 Custom Manufacturing
    • 4.3.2 Assay Development
    • 4.3.3 Analytical Services
    • 4.3.4 Regulatory Support
    • 4.3.5 Logistics
  • 4.4 Market Size & Forecast by Technology (2020-2035)
    • 4.4.1 PCR
    • 4.4.2 NGS
    • 4.4.3 ELISA
    • 4.4.4 Mass Spectrometry
    • 4.4.5 Flow Cytometry
  • 4.5 Market Size & Forecast by Component (2020-2035)
    • 4.5.1 Antibodies
    • 4.5.2 Nucleic Acids
    • 4.5.3 Enzymes
    • 4.5.4 Buffers
    • 4.5.5 Stabilizers
  • 4.6 Market Size & Forecast by Application (2020-2035)
    • 4.6.1 Infectious Diseases
    • 4.6.2 Cancer
    • 4.6.3 Cardiology
    • 4.6.4 Diabetes
    • 4.6.5 Nephrology
  • 4.7 Market Size & Forecast by End User (2020-2035)
    • 4.7.1 Hospitals
    • 4.7.2 Diagnostic Laboratories
    • 4.7.3 Research Institutes
    • 4.7.4 Biopharmaceutical Companies
  • 4.8 Market Size & Forecast by Process (2020-2035)
    • 4.8.1 Formulation
    • 4.8.2 Lyophilization
    • 4.8.3 Filling
    • 4.8.4 Packaging
    • 4.8.5 Labeling
  • 4.9 Market Size & Forecast by Device (2020-2035)
    • 4.9.1 Benchtop
    • 4.9.2 Portable
    • 4.9.3 Handheld
    • 4.9.4 Automated
    • 4.9.5 Semi-automated

5 Regional Analysis

  • 5.1 Global Market Overview
  • 5.2 North America Market Size (2020-2035)
    • 5.2.1 United States
      • 5.2.1.1 Type
      • 5.2.1.2 Product
      • 5.2.1.3 Services
      • 5.2.1.4 Technology
      • 5.2.1.5 Component
      • 5.2.1.6 Application
      • 5.2.1.7 End User
      • 5.2.1.8 Process
      • 5.2.1.9 Device
    • 5.2.2 Canada
      • 5.2.2.1 Type
      • 5.2.2.2 Product
      • 5.2.2.3 Services
      • 5.2.2.4 Technology
      • 5.2.2.5 Component
      • 5.2.2.6 Application
      • 5.2.2.7 End User
      • 5.2.2.8 Process
      • 5.2.2.9 Device
    • 5.2.3 Mexico
      • 5.2.3.1 Type
      • 5.2.3.2 Product
      • 5.2.3.3 Services
      • 5.2.3.4 Technology
      • 5.2.3.5 Component
      • 5.2.3.6 Application
      • 5.2.3.7 End User
      • 5.2.3.8 Process
      • 5.2.3.9 Device
  • 5.3 Latin America Market Size (2020-2035)
    • 5.3.1 Brazil
      • 5.3.1.1 Type
      • 5.3.1.2 Product
      • 5.3.1.3 Services
      • 5.3.1.4 Technology
      • 5.3.1.5 Component
      • 5.3.1.6 Application
      • 5.3.1.7 End User
      • 5.3.1.8 Process
      • 5.3.1.9 Device
    • 5.3.2 Argentina
      • 5.3.2.1 Type
      • 5.3.2.2 Product
      • 5.3.2.3 Services
      • 5.3.2.4 Technology
      • 5.3.2.5 Component
      • 5.3.2.6 Application
      • 5.3.2.7 End User
      • 5.3.2.8 Process
      • 5.3.2.9 Device
    • 5.3.3 Rest of Latin America
      • 5.3.3.1 Type
      • 5.3.3.2 Product
      • 5.3.3.3 Services
      • 5.3.3.4 Technology
      • 5.3.3.5 Component
      • 5.3.3.6 Application
      • 5.3.3.7 End User
      • 5.3.3.8 Process
      • 5.3.3.9 Device
  • 5.4 Asia-Pacific Market Size (2020-2035)
    • 5.4.1 China
      • 5.4.1.1 Type
      • 5.4.1.2 Product
      • 5.4.1.3 Services
      • 5.4.1.4 Technology
      • 5.4.1.5 Component
      • 5.4.1.6 Application
      • 5.4.1.7 End User
      • 5.4.1.8 Process
      • 5.4.1.9 Device
    • 5.4.2 India
      • 5.4.2.1 Type
      • 5.4.2.2 Product
      • 5.4.2.3 Services
      • 5.4.2.4 Technology
      • 5.4.2.5 Component
      • 5.4.2.6 Application
      • 5.4.2.7 End User
      • 5.4.2.8 Process
      • 5.4.2.9 Device
    • 5.4.3 South Korea
      • 5.4.3.1 Type
      • 5.4.3.2 Product
      • 5.4.3.3 Services
      • 5.4.3.4 Technology
      • 5.4.3.5 Component
      • 5.4.3.6 Application
      • 5.4.3.7 End User
      • 5.4.3.8 Process
      • 5.4.3.9 Device
    • 5.4.4 Japan
      • 5.4.4.1 Type
      • 5.4.4.2 Product
      • 5.4.4.3 Services
      • 5.4.4.4 Technology
      • 5.4.4.5 Component
      • 5.4.4.6 Application
      • 5.4.4.7 End User
      • 5.4.4.8 Process
      • 5.4.4.9 Device
    • 5.4.5 Australia
      • 5.4.5.1 Type
      • 5.4.5.2 Product
      • 5.4.5.3 Services
      • 5.4.5.4 Technology
      • 5.4.5.5 Component
      • 5.4.5.6 Application
      • 5.4.5.7 End User
      • 5.4.5.8 Process
      • 5.4.5.9 Device
    • 5.4.6 Taiwan
      • 5.4.6.1 Type
      • 5.4.6.2 Product
      • 5.4.6.3 Services
      • 5.4.6.4 Technology
      • 5.4.6.5 Component
      • 5.4.6.6 Application
      • 5.4.6.7 End User
      • 5.4.6.8 Process
      • 5.4.6.9 Device
    • 5.4.7 Rest of APAC
      • 5.4.7.1 Type
      • 5.4.7.2 Product
      • 5.4.7.3 Services
      • 5.4.7.4 Technology
      • 5.4.7.5 Component
      • 5.4.7.6 Application
      • 5.4.7.7 End User
      • 5.4.7.8 Process
      • 5.4.7.9 Device
  • 5.5 Europe Market Size (2020-2035)
    • 5.5.1 Germany
      • 5.5.1.1 Type
      • 5.5.1.2 Product
      • 5.5.1.3 Services
      • 5.5.1.4 Technology
      • 5.5.1.5 Component
      • 5.5.1.6 Application
      • 5.5.1.7 End User
      • 5.5.1.8 Process
      • 5.5.1.9 Device
    • 5.5.2 France
      • 5.5.2.1 Type
      • 5.5.2.2 Product
      • 5.5.2.3 Services
      • 5.5.2.4 Technology
      • 5.5.2.5 Component
      • 5.5.2.6 Application
      • 5.5.2.7 End User
      • 5.5.2.8 Process
      • 5.5.2.9 Device
    • 5.5.3 United Kingdom
      • 5.5.3.1 Type
      • 5.5.3.2 Product
      • 5.5.3.3 Services
      • 5.5.3.4 Technology
      • 5.5.3.5 Component
      • 5.5.3.6 Application
      • 5.5.3.7 End User
      • 5.5.3.8 Process
      • 5.5.3.9 Device
    • 5.5.4 Spain
      • 5.5.4.1 Type
      • 5.5.4.2 Product
      • 5.5.4.3 Services
      • 5.5.4.4 Technology
      • 5.5.4.5 Component
      • 5.5.4.6 Application
      • 5.5.4.7 End User
      • 5.5.4.8 Process
      • 5.5.4.9 Device
    • 5.5.5 Italy
      • 5.5.5.1 Type
      • 5.5.5.2 Product
      • 5.5.5.3 Services
      • 5.5.5.4 Technology
      • 5.5.5.5 Component
      • 5.5.5.6 Application
      • 5.5.5.7 End User
      • 5.5.5.8 Process
      • 5.5.5.9 Device
    • 5.5.6 Rest of Europe
      • 5.5.6.1 Type
      • 5.5.6.2 Product
      • 5.5.6.3 Services
      • 5.5.6.4 Technology
      • 5.5.6.5 Component
      • 5.5.6.6 Application
      • 5.5.6.7 End User
      • 5.5.6.8 Process
      • 5.5.6.9 Device
  • 5.6 Middle East & Africa Market Size (2020-2035)
    • 5.6.1 Saudi Arabia
      • 5.6.1.1 Type
      • 5.6.1.2 Product
      • 5.6.1.3 Services
      • 5.6.1.4 Technology
      • 5.6.1.5 Component
      • 5.6.1.6 Application
      • 5.6.1.7 End User
      • 5.6.1.8 Process
      • 5.6.1.9 Device
    • 5.6.2 United Arab Emirates
      • 5.6.2.1 Type
      • 5.6.2.2 Product
      • 5.6.2.3 Services
      • 5.6.2.4 Technology
      • 5.6.2.5 Component
      • 5.6.2.6 Application
      • 5.6.2.7 End User
      • 5.6.2.8 Process
      • 5.6.2.9 Device
    • 5.6.3 South Africa
      • 5.6.3.1 Type
      • 5.6.3.2 Product
      • 5.6.3.3 Services
      • 5.6.3.4 Technology
      • 5.6.3.5 Component
      • 5.6.3.6 Application
      • 5.6.3.7 End User
      • 5.6.3.8 Process
      • 5.6.3.9 Device
    • 5.6.4 Sub-Saharan Africa
      • 5.6.4.1 Type
      • 5.6.4.2 Product
      • 5.6.4.3 Services
      • 5.6.4.4 Technology
      • 5.6.4.5 Component
      • 5.6.4.6 Application
      • 5.6.4.7 End User
      • 5.6.4.8 Process
      • 5.6.4.9 Device
    • 5.6.5 Rest of MEA
      • 5.6.5.1 Type
      • 5.6.5.2 Product
      • 5.6.5.3 Services
      • 5.6.5.4 Technology
      • 5.6.5.5 Component
      • 5.6.5.6 Application
      • 5.6.5.7 End User
      • 5.6.5.8 Process
      • 5.6.5.9 Device

6 Market Strategy

  • 6.1 Demand-Supply Gap Analysis
  • 6.2 Trade & Logistics Constraints
  • 6.3 Price-Cost-Margin Trends
  • 6.4 Market Penetration
  • 6.5 Consumer Analysis
  • 6.6 Regulatory Snapshot

7 Competitive Intelligence

  • 7.1 Market Positioning
  • 7.2 Market Share
  • 7.3 Competition Benchmarking
  • 7.4 Top Company Strategies

8 Company Profiles

  • 8.1 Alere
    • 8.1.1 Overview
    • 8.1.2 Product Summary
    • 8.1.3 Financial Performance
    • 8.1.4 SWOT Analysis
  • 8.2 Bio- Techne
    • 8.2.1 Overview
    • 8.2.2 Product Summary
    • 8.2.3 Financial Performance
    • 8.2.4 SWOT Analysis
  • 8.3 Bio- Rad Laboratories
    • 8.3.1 Overview
    • 8.3.2 Product Summary
    • 8.3.3 Financial Performance
    • 8.3.4 SWOT Analysis
  • 8.4 Dia Sorin
    • 8.4.1 Overview
    • 8.4.2 Product Summary
    • 8.4.3 Financial Performance
    • 8.4.4 SWOT Analysis
  • 8.5 ELITech Group
    • 8.5.1 Overview
    • 8.5.2 Product Summary
    • 8.5.3 Financial Performance
    • 8.5.4 SWOT Analysis
  • 8.6 Fujirebio
    • 8.6.1 Overview
    • 8.6.2 Product Summary
    • 8.6.3 Financial Performance
    • 8.6.4 SWOT Analysis
  • 8.7 Grifols
    • 8.7.1 Overview
    • 8.7.2 Product Summary
    • 8.7.3 Financial Performance
    • 8.7.4 SWOT Analysis
  • 8.8 Hologic
    • 8.8.1 Overview
    • 8.8.2 Product Summary
    • 8.8.3 Financial Performance
    • 8.8.4 SWOT Analysis
  • 8.9 Kreatech Diagnostics
    • 8.9.1 Overview
    • 8.9.2 Product Summary
    • 8.9.3 Financial Performance
    • 8.9.4 SWOT Analysis
  • 8.10 Luminex Corporation
    • 8.10.1 Overview
    • 8.10.2 Product Summary
    • 8.10.3 Financial Performance
    • 8.10.4 SWOT Analysis
  • 8.11 Meridian Bioscience
    • 8.11.1 Overview
    • 8.11.2 Product Summary
    • 8.11.3 Financial Performance
    • 8.11.4 SWOT Analysis
  • 8.12 Ortho Clinical Diagnostics
    • 8.12.1 Overview
    • 8.12.2 Product Summary
    • 8.12.3 Financial Performance
    • 8.12.4 SWOT Analysis
  • 8.13 Perkin Elmer
    • 8.13.1 Overview
    • 8.13.2 Product Summary
    • 8.13.3 Financial Performance
    • 8.13.4 SWOT Analysis
  • 8.14 Quidel Corporation
    • 8.14.1 Overview
    • 8.14.2 Product Summary
    • 8.14.3 Financial Performance
    • 8.14.4 SWOT Analysis
  • 8.15 Randox Laboratories
    • 8.15.1 Overview
    • 8.15.2 Product Summary
    • 8.15.3 Financial Performance
    • 8.15.4 SWOT Analysis
  • 8.16 Roche Diagnostics
    • 8.16.1 Overview
    • 8.16.2 Product Summary
    • 8.16.3 Financial Performance
    • 8.16.4 SWOT Analysis
  • 8.17 Sekisui Diagnostics
    • 8.17.1 Overview
    • 8.17.2 Product Summary
    • 8.17.3 Financial Performance
    • 8.17.4 SWOT Analysis
  • 8.18 Sysmex Corporation
    • 8.18.1 Overview
    • 8.18.2 Product Summary
    • 8.18.3 Financial Performance
    • 8.18.4 SWOT Analysis
  • 8.19 Thermo Fisher Scientific
    • 8.19.1 Overview
    • 8.19.2 Product Summary
    • 8.19.3 Financial Performance
    • 8.19.4 SWOT Analysis
  • 8.20 Werfen
    • 8.20.1 Overview
    • 8.20.2 Product Summary
    • 8.20.3 Financial Performance
    • 8.20.4 SWOT Analysis

9 About Us

  • 9.1 About Us
  • 9.2 Research Methodology
  • 9.3 Research Workflow
  • 9.4 Consulting Services
  • 9.5 Our Clients
  • 9.6 Client Testimonials
  • 9.7 Contact Us